Genomic Epidemiology of Carbapenemase-Producing Enterobacterales at a Hospital System in Toronto, Ontario, Canada, 2007 to 2018

被引:5
|
作者
Jamal, Alainna J. [1 ,2 ]
Mataseje, Laura F. [3 ]
Williams, Victoria [4 ]
Leis, Jerome A. [1 ,4 ]
Tijet, Nathalie [5 ]
Zittermann, Sandra [5 ]
Melano, Roberto G. [5 ]
Mulvey, Michael R. [3 ]
Katz, Kevin [4 ]
Allen, Vanessa G. [4 ]
McGeer, Allison J. [1 ,2 ]
机构
[1] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[2] Sinai Hlth Syst, Toronto, ON, Canada
[3] Natl Microbiol Lab, Winnipeg, MB, Canada
[4] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[5] Publ Hlth Ontario Lab, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
carbapenem-resistant Enterobacteriaceae; beta-lactamases; disease transmission; genomic epidemiology; public health; KLEBSIELLA-PNEUMONIAE; RESISTANT; OUTBREAK;
D O I
10.1128/AAC.00360-21
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
At a hospital system (H1) in Ontario, Canada, we investigated whether whole-genome sequencing (WGS) altered initial epidemiological interpretation of carbapenemase-producing Enterobacterales (CPE) transmission. We included patients with CPE colonization/infection identified by population-based surveillance from October 2007 to August 2018 who received health care at H1 in the year before/after CPE detection. H1 reported epidemiological transmission clusters. We combined single nucleotide variant (SNV) analysis, plasmid characterization, and epidemiological data. Eighty-five patients were included. H1 identified 7 epidemiological transmission clusters, namely, A to G, involving 24/85 (28%) patients. SNV analysis confirmed transmission clusters C, D, and G and identified two additional cases belonging to cluster A. One was a travel-related case that was the likely index case (0 to 6 SNVs from other isolates); this case stayed on the same unit as the initially presumed index case 4months prior to detection of the initially presumed index case on another unit. The second additional case occupied a room previously occupied by 5 cluster A cases. Plasmid sequence analysis excluded a case from cluster A and identified clusters E and F as possibly two parts of a single cluster. SNV analysis also identified a case without direct epidemiologic links that was 18 to 21 SNVs away from cluster B, suggesting possible undetected interhospital transmission. SNV and plasmid sequence analysis identified cases belonging to transmission clusters that conventional epidemiology missed and excluded other cases. Implementation of routine WGS to complement epidemiological transmission investigations has the potential to improve prevention and control of CPE in hospitals.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health
    Alvisi, Gualtiero
    Curtoni, Antonio
    Fonnesu, Rossella
    Piazza, Aurora
    Signoretto, Caterina
    Piccinini, Giorgia
    Sassera, Davide
    Gaibani, Paolo
    ANTIBIOTICS-BASEL, 2025, 14 (02):
  • [22] Molecular epidemiology characteristics and detecting transmission of carbapenemase-producing enterobacterales in southwestern China
    Deng, Jin
    Liao, Quanfeng
    Zhang, Weili
    Wu, Siying
    Liu, Ya
    Xiao, YuLing
    Kang, Mei
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (10) : 1047 - 1052
  • [23] Active surveillance of carbapenemase-producing Enterobacterales using genomic sequencing for hospital-based infection control interventions
    Lee, Andie S.
    Dolan, Leanne
    Jenkins, Frances
    Crawford, Bernadette
    van Hal, Sebastiaan J.
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2024, 45 (02) : 137 - 143
  • [24] Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada
    Kohler, Philipp P.
    Melano, Roberto G.
    Patel, Samir N.
    Shafinaz, Shumona
    Faheem, Amna
    Coleman, Brenda L.
    Green, Karen
    Armstrong, Irene
    Almohri, Huda
    Borgia, Sergio
    Borgundvaag, Emily
    Johnstone, Jennie
    Katz, Kevin
    Lam, Freda
    Muller, Matthew P.
    Powis, Jeff
    Poutanen, Susan M.
    Richardson, David
    Rebbapragada, Anu
    Sarabia, Alicia
    Simor, Andrew
    McGeer, Allison
    EMERGING INFECTIOUS DISEASES, 2018, 24 (09) : 1674 - 1682
  • [25] Phenotypic and Genetic Characteristics of Carbapenemase-Producing Enterobacterales Isolates at Okayama University Hospital
    Gotoh, Kazuyoshi
    Miyoshi, Makoto
    Mayura, I. Putu Bayu
    Tsuji, Shuma
    Iio, Koji
    Fukushima, Shinnosuke
    Matsushita, Osamu
    Hagiya, Hideharu
    ACTA MEDICA OKAYAMA, 2024, 78 (05) : 371 - 376
  • [26] Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its "Sell-By Date" in an Era of New Antibiotics and Regional Carbapenemase Epidemiology
    Livermore, David M.
    Nicolau, David P.
    Hopkins, Katie L.
    Meunier, Daniele
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (07) : 1776 - 1782
  • [27] Epidemiology of Carbapenemase-Producing Klebsiella pneumoniae in a Portuguese Tertiary Hospital
    Peres, D.
    Pereira-Rocha, N.
    Alves, C.
    Correia, S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30
  • [28] Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterales in neonatal patients
    Jiansheng Wang
    Yuanpeng Lv
    Weiwei Yang
    Peng Zhao
    Changfu Yin
    BMC Microbiology, 22
  • [29] Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterales in neonatal patients
    Wang, Jiansheng
    Lv, Yuanpeng
    Yang, Weiwei
    Zhao, Peng
    Yin, Changfu
    BMC MICROBIOLOGY, 2022, 22 (01)
  • [30] Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017-2019
    Wielders, Cornelia C. H.
    Schouls, Leo M.
    Woudt, Sjoukje H. S.
    Notermans, Daan W.
    Hendrickx, Antoni P. A.
    Bakker, Jacinta
    Kuijper, Ed J.
    Schoffelen, Annelot F.
    de Greeff, Sabine C.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2022, 11 (01)